| CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (NCT00099138) | National Institute on Aging (NIA) | 2002-03-01 |
| Sertraline Hydrochloride 100 mg Tablets, Fasting (NCT00836849) | Teva Pharmaceuticals USA | 2002-03-01 |
| Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00040950) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients (NCT00036634) | Gilead Sciences | 2002-03-01 |
| Glycemic Load, Weight Loss and Cardiovascular Disease Risk (NCT00254215) | University of Sydney | 2002-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer (NCT00039091) | National Cancer Institute (NCI) | 2002-03-01 |
| ABT-751 in Treating Young Patients With Refractory Solid Tumors (NCT00036959) | National Institutes of Health Clinical Center (CC) | 2002-03-01 |
| Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. (NCT00289341) | Rockefeller University | 2002-03-01 |
| Study of gp75 Vaccine in Patients With Stage III and IV Melanoma (NCT00034554) | Eli Lilly and Company | 2002-03-01 |
| Sertraline Hydrochloride 100 mg Tablets, Fed (NCT00836667) | Teva Pharmaceuticals USA | 2002-03-01 |
| Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers (NCT01678976) | Bial - Portela C S.A. | 2002-03-01 |
| Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer (NCT00320983) | University of New Mexico | 2002-03-01 |
| Treatment of Orthostatic Hypotension in Autonomic Failure (NCT00223691) | Vanderbilt University | 2002-03-01 |
| CC-5013 in Treating Patients With Recurrent Glioma (NCT00036894) | National Cancer Institute (NCI) | 2002-03-01 |
| This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. (NCT00032903) | Sigma-Tau Research, Inc. | 2002-03-01 |
| Inhaled Bicarbonate Therapy in Cystic Fibrosis (NCT00177645) | University of Pittsburgh | 2002-03-01 |
| Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions (NCT00833937) | Teva Pharmaceuticals USA | 2002-03-01 |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer (NCT00653757) | Mayo Clinic | 2002-03-01 |
| A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma (NCT00039754) | Poniard Pharmaceuticals | 2002-03-01 |
| Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma (NCT00056173) | Aptose Biosciences Inc. | 2002-03-01 |
| Brief Cognitive-Behavioral Treatment for Victims of Mass Violence (NCT00495027) | Boston University | 2002-03-01 |
| Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) (NCT01127074) | University Hospital Tuebingen | 2002-03-01 |
| A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions (NCT00864669) | Actavis Inc. | 2002-03-01 |
| Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects (NCT02170610) | Boehringer Ingelheim | 2002-03-01 |
| Biological Therapy in Treating Patients With Prostate Cancer (NCT00039299) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00346385) | ImmunoGen, Inc. | 2002-03-01 |
| Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) (NCT00037141) | American Medical Systems | 2002-03-01 |
| Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma (NCT00988312) | University Hospital Carl Gustav Carus | 2002-03-01 |
| A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies (NCT00055263) | Novacea | 2002-03-01 |
| A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma (NCT00034138) | Unither Pharmaceuticals | 2002-03-01 |
| Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer (NCT00153907) | Dana-Farber Cancer Institute | 2002-03-01 |
| CPG 7909 in Patients Wih Stage IV Renal Cell Cancer (NCT00043407) | Pfizer | 2002-03-01 |
| UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00036777) | National Cancer Institute (NCI) | 2002-03-01 |
| Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme (NCT00052208) | National Cancer Institute (NCI) | 2002-03-01 |
| Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax® (NCT00042094) | DynPort Vaccine Company LLC, A GDIT Company | 2002-03-01 |
| CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (NCT00099099) | National Institute on Aging (NIA) | 2002-03-01 |
| Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma (NCT00039325) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT (NCT00586274) | Baylor College of Medicine | 2002-03-01 |
| Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds (NCT00161759) | Baxter Healthcare Corporation | 2002-03-01 |
| Electrical Stimulation After Total Knee Arthroplasty (NCT00224913) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-03-01 |
| Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ (NCT00290745) | University of California, San Francisco | 2002-02-19 |
| Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects (NCT02273466) | Boehringer Ingelheim | 2002-02-01 |
| Analgesic Efficacy of Smoked Cannabis (NCT00241579) | Center for Medicinal Cannabis Research | 2002-02-01 |
| Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors (NCT00193570) | SCRI Development Innovations, LLC | 2002-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors (NCT00052403) | Barbara Ann Karmanos Cancer Institute | 2002-02-01 |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis (NCT00424489) | Northwestern University | 2002-02-01 |
| Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer (NCT01278914) | Oslo University Hospital | 2002-02-01 |
| Lantus in Prediabetes (NCT00348972) | Sanofi | 2002-02-01 |
| Patching for Lazy Eye: Trial to Evaluate Daily Patching Amounts (NCT00274664) | City, University of London | 2002-02-01 |
| Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers (NCT00357539) | Laboratoires Thea | 2002-02-01 |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer (NCT00036517) | PhytoCeutica | 2002-02-01 |
| A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) (NCT00230321) | Peter L Greenberg | 2002-02-01 |
| Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions (NCT00833521) | Teva Pharmaceuticals USA | 2002-02-01 |
| KRN5500 in Treating Patients With Solid Tumors (NCT00017238) | National Cancer Institute (NCI) | 2002-02-01 |
| Prevention of Myopia of Prematurity by Calcium Supplementation (NCT00892476) | University of Alabama at Birmingham | 2002-02-01 |
| Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects (NCT02170623) | Boehringer Ingelheim | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Lamotrigine 25 mg Chewable Tablets, Non-Fasting (NCT00838136) | Teva Pharmaceuticals USA | 2002-02-01 |
| Islet Transplantation in Type 1 Diabetic Patients (NCT00214253) | University of Wisconsin, Madison | 2002-02-01 |
| Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) (NCT00657007) | Human Genome Sciences Inc. | 2002-02-01 |
| Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function (NCT00137475) | AHS Cancer Control Alberta | 2002-02-01 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00053105) | Theradex | 2002-02-01 |
| Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00033449) | National Cancer Institute (NCI) | 2002-02-01 |
| Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma (NCT00730613) | City of Hope Medical Center | 2002-02-01 |
| Lamotrigine 25 mg Chewable Tablets, Fasting (NCT00838279) | Teva Pharmaceuticals USA | 2002-02-01 |
| Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista) (NCT00978367) | Renovo | 2002-02-01 |
| Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects (NCT02269202) | Boehringer Ingelheim | 2002-02-01 |
| PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2) (NCT00045942) | Novartis Pharmaceuticals | 2002-01-30 |
| Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD (NCT00032773) | Astex Pharmaceuticals, Inc. | 2002-01-30 |
| Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma (NCT00027625) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-01-28 |
| Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation (NCT01157143) | Sanofi | 2002-01-01 |
| Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors (NCT00031928) | National Cancer Institute (NCI) | 2002-01-01 |
| Development of an Intranasal Proteosome Influenza Vaccine (NCT02522754) | Hvivo | 2002-01-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers (NCT02181309) | Boehringer Ingelheim | 2002-01-01 |
| Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation (NCT00031642) | University of Nebraska | 2002-01-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00028821) | National Cancer Institute (NCI) | 2002-01-01 |
| Karenitecin in Treating Patients With Recurrent Malignant Glioma (NCT00014521) | National Cancer Institute (NCI) | 2002-01-01 |
| Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy (NCT01521611) | University Hospital Southampton NHS Foundation Trust | 2002-01-01 |
| Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions (NCT01286688) | Dr. Reddy's Laboratories Limited | 2002-01-01 |
| BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00057850) | National Cancer Institute (NCI) | 2002-01-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00033228) | Mannkind Corporation | 2002-01-01 |
| Study on the Effect of Prostacyclin Compared to Placebo in Traumatic Brain Injury (NCT01363583) | Umeå University | 2002-01-01 |
| Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors (NCT00049023) | O'Dorisio, M S | 2002-01-01 |
| Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND) (NCT00164346) | Centers for Disease Control and Prevention | 2002-01-01 |
| Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer (NCT00033345) | University of Kansas Medical Center | 2002-01-01 |
| Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00027898) | National Cancer Institute (NCI) | 2002-01-01 |
| Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions (NCT00835263) | Teva Pharmaceuticals USA | 2002-01-01 |
| Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma (NCT00575068) | Biogen | 2002-01-01 |
| Interactive Computer Treatment for Panic Disorder (NCT00063375) | Florida State University | 2002-01-01 |
| Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions (NCT01286701) | Dr. Reddy's Laboratories Limited | 2002-01-01 |
| Disulfiram in Patients With Metastatic Melanoma (NCT00256230) | John P. Fruehauf | 2002-01-01 |
| XK469 in Treating Patients With Advanced Solid Tumors (NCT00028548) | Barbara Ann Karmanos Cancer Institute | 2002-01-01 |
| Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis (NCT01020396) | Teva Pharmaceuticals USA | 2002-01-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis (NCT00154609) | National Taiwan University Hospital | 2002-01-01 |
| STI571 in Treating Patients With Recurrent Leukemia (NCT00004932) | Children's Oncology Group | 2002-01-01 |
| Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases (NCT00028652) | University of Wisconsin, Madison | 2002-01-01 |
| Weight-bearing Recommendation After Replacement of the Hip or Knee Joint (NCT00266396) | Verein zur Förderung der Rehabilitationsforschung in Schleswig-Holstein | 2002-01-01 |
| Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions (NCT00834561) | Teva Pharmaceuticals USA | 2002-01-01 |